Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

08 July 2021: Clinical Research

Transurethral Microwave Thermotherapy (TUMT) in the Treatment of Benign Prostatic Hyperplasia: A Preliminary Report

Roger J. Ziętek 1BDF , Zbigniew M. Ziętek 123ACE*

DOI: 10.12659/MSM.931597

Med Sci Monit 2021; 27:e931597

Table 2 Baseline and 6-month follow-up International Prostate Symptom Score of patients in the transurethral microwave thermotherapy (TUMT) and pharmacologic (control) groups. P, P1, P2, and P3 indicate statistical significance according to the Z test: P, baseline comparison between TUMT and control group; P1, 6-month follow-up comparison between the TUMT and control groups; P2, only within the TUMT group, baseline vs 6-month follow-up; P3, only within the control group, baseline vs 6-month follow-up.

IPSS scale symptomsBeforeAfterP, P1 P2, P3
n (%)n (%)
Mild98 (12%)125 (13%)527 (63%)485 (47%)
Moderate612 (73%)756 (72%)278 (33%)458 (44%)
Severe130 (15%)159 (15%)35 (4%)97 (9%)
Total840 (100%)1040 (100%)840 (100%)1040 (100%)
IPSS – International Prostate Symptom Score; TUMT – transurethral microwave thermotherapy.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750